Generation of Knockout Rats with X-Linked Severe Combined Immunodeficiency (X-SCID) Using Zinc-Finger Nucleases

Background Although the rat is extensively used as a laboratory model, the inability to utilize germ line-competent rat embryonic stem (ES) cells has been a major drawback for studies that aim to elucidate gene functions. Recently, zinc-finger nucleases (ZFNs) were successfully used to create genome-specific double-stranded breaks and thereby induce targeted gene mutations in a wide variety of organisms including plants, drosophila, zebrafish, etc. Methodology/Principal Findings We report here on ZFN-induced gene targeting of the rat interleukin 2 receptor gamma (Il2rg) locus, where orthologous human and mouse mutations cause X-linked severe combined immune deficiency (X-SCID). Co-injection of mRNAs encoding custom-designed ZFNs into the pronucleus of fertilized oocytes yielded genetically modified offspring at rates greater than 20%, which possessed a wide variety of deletion/insertion mutations. ZFN-modified founders faithfully transmitted their genetic changes to the next generation along with the severe combined immune deficiency phenotype. Conclusions and Significance The efficient and rapid generation of gene knockout rats shows that using ZFN technology is a new strategy for creating gene-targeted rat models of human diseases. In addition, the X-SCID rats that were established in this study will be valuable in vivo tools for evaluating drug treatment or gene therapy as well as model systems for examining the treatment of xenotransplanted malignancies.

[1]  R. Hu,et al.  Production of knockout rats using ENU mutagenesis and a yeast-based screening assay , 2003, Nature Biotechnology.

[2]  M. Oettinger,et al.  DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect , 1995, Science.

[3]  R. Jaenisch,et al.  Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases , 2009, Nature Biotechnology.

[4]  Ignacio Anegon,et al.  Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases , 2009, Science.

[5]  Takuji Tanaka,et al.  Enhanced colitis‐associated colon carcinogenesis in a novel Apc mutant rat , 2009, Cancer science.

[6]  Adam James Waite,et al.  An improved zinc-finger nuclease architecture for highly specific genome editing , 2007, Nature Biotechnology.

[7]  S. Chandrasegaran,et al.  Custom-designed zinc finger nucleases: What is next? , 2007, Cellular and Molecular Life Sciences.

[8]  Hui Li,et al.  Generation of induced pluripotent stem cell lines from adult rat cells. , 2009, Cell stem cell.

[9]  Dale L. Greiner,et al.  Humanized mice in translational biomedical research , 2007, Nature Reviews Immunology.

[10]  Austin G Smith,et al.  Capture of Authentic Embryonic Stem Cells from Rat Blastocysts , 2008, Cell.

[11]  M. Katsuki,et al.  Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. , 1996, Blood.

[12]  A. Klug,et al.  Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases , 2008, Proceedings of the National Academy of Sciences.

[13]  Tadao Serikawa,et al.  Pluripotent stem cells and other technologies will eventually open the door for straightforward gene targeting in the rat , 2009, Disease Models & Mechanisms.

[14]  N. Nakatsuji,et al.  Rats produced by interspecies spermatogonial transplantation in mice and in vitro microinsemination , 2006, Proceedings of the National Academy of Sciences.

[15]  K. Kitada,et al.  Transposon-tagged mutagenesis in the rat , 2007, Nature Methods.

[16]  Jeffrey C. Miller,et al.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases , 2005, Nature.

[17]  T. Hocking,et al.  Heritable Targeted Gene Disruption in Zebrafish Using Designed Zinc Finger Nucleases , 2008, Nature Biotechnology.

[18]  Mark Shackleton,et al.  Efficient tumour formation by single human melanoma cells , 2008 .

[19]  Sheng Ding,et al.  Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. , 2009, Cell stem cell.

[20]  W. Leonard,et al.  Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. , 1995, Immunity.

[21]  W. Leonard Cytokines and immunodeficiency diseases , 2001, Nature Reviews Immunology.

[22]  F. Alt,et al.  Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation , 1995, Cell.

[23]  Vitali Alexeev,et al.  Targeted manipulation of mammalian genomes using designed zinc finger nucleases. , 2009, Biochemical and biophysical research communications.

[24]  J. Nolta,et al.  Animal xenograft models for evaluation of gene transfer into human hematopoietic stem cells. , 1999, Current opinion in molecular therapeutics.

[25]  A. Fischer,et al.  Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Nakahata,et al.  NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models. , 2008, Current topics in microbiology and immunology.

[27]  Edwin Cuppen,et al.  Generation of gene knockouts and mutant models in the laboratory rat by ENU-driven target-selected mutagenesis , 2006, Pharmacogenetics and genomics.

[28]  K. Machida,et al.  Higher susceptibility of NOG mice to xenotransplanted tumors. , 2009, The Journal of toxicological sciences.

[29]  R. Brinster,et al.  Conservation of spermatogonial stem cell self-renewal signaling between mouse and rat. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. Leonard,et al.  Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans , 1993, Cell.

[31]  Tadao Serikawa,et al.  An ENU-induced mutant archive for gene targeting in rats , 2008, Nature Genetics.

[32]  C. Hsieh,et al.  Germline Competent Embryonic Stem Cells Derived from Rat Blastocysts , 2008, Cell.

[33]  M. Thomsen,et al.  Reconstitution of a human immune system in immunodeficient mice: models of human alloreaction in vivo. , 2005, Tissue antigens.

[34]  Dana Carroll,et al.  Gene targeting using zinc finger nucleases , 2005, Nature Biotechnology.